| 中文名称 | 特拉唑嗪 |
| 英文名称 | Terazosin |
| CAS号 | 63590-64-7 |
| 分子式 | C19H25N5O4 |
| 分子量 | 387.43 |
| EINECS号 | 613-265-8 |
| 熔点 | 281-283°C |
| 沸点 | 664.5±65.0 °C(Predicted) |
| 密度 | 1.332±0.06 g/cm3(Predicted) |
| 溶解度 | 在水中的溶解度25 mg/mL |
| 形态 | 粉末 |
| 酸度系数(pKa) | pKa (0.1N NaOH): 7.1(at 25℃) |
| 颜色 | 白色至类白色 |
| 水溶解性 | 30.6mg/L(22.5 ºC) |
| 危险品标志 | Xn,Xi |
| 危险类别码 | 22-36/37/38 |
| 安全说明 | 26-36 |
| WGK Germany | 3 |
| RTECS号 | TK8044925 |
α1-adrenoceptor
Terazosin does not discriminate cloned α1-adrenoceptor subtypes transiently expressed in COS cells.
Terazosin can be used to promote stone discharge in treatment of ureteral stones. Terazosin is reportedly safe and effective in treatment of distal ureteral stones, especially stones >5 mm.